Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
45,782,552
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
2,320,262
-
Shares change
-
-170,459
-
Total reported value, excl. options
-
$6,798,547
-
Value change
-
-$740,098
-
Put/Call ratio
-
3.96%
-
Number of buys
-
8
-
Number of sells
-
-10
-
Price
-
$2.93
Significant Holders of CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) as of Q4 2021
36 filings reported holding CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock as of Q4 2021.
CAPRICOR THERAPEUTICS, INC. - Common Stock (CAPR) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,320,262 shares
of 45,782,552 outstanding shares and own 5.07% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (966,738 shares), BlackRock Inc. (302,984 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (214,601 shares), GEODE CAPITAL MANAGEMENT, LLC (205,572 shares), NORTHERN TRUST CORP (103,923 shares), DIMENSIONAL FUND ADVISORS LP (96,157 shares), Bank of New York Mellon Corp (85,375 shares), CITADEL ADVISORS LLC (79,838 shares), STATE STREET CORP (71,748 shares), and SIMPLEX TRADING, LLC (35,291 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.